Does serum growth hormone (GH) binding protein reflect human GH receptor function?

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 3, 2000, Pages 927-932

  Amit, Tamar ^a   Youdim, Moussa B H ^a   Hochberg, Ze'ev ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C; CARRIER PROTEIN; HUMAN GROWTH HORMONE; SOMATOTROPIN BINDING PROTEIN; SOMATOTROPIN-BINDING PROTEIN;

ARTICLE; CRITICAL ILLNESS; DIAGNOSTIC TEST; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HORMONE RECEPTOR INTERACTION; HUMAN; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; INTERNALIZATION; KIDNEY FAILURE; LIVER CIRRHOSIS; MALNUTRITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA SPLICING; SCREENING TEST; ANIMAL; BIOSYNTHESIS; BLOOD; GENETICS; METABOLISM; REVIEW;

ANIMALIA;

ANIMALS; CARRIER PROTEINS; HUMAN GROWTH HORMONE; HUMANS; RECEPTORS, SOMATOTROPIN;

EID: 85047684340     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.3.6461     Document Type: Article

References (100)

1. A specific growth hormone-binding protein in human plasma: Initial characterization
2. Identification and characterization of specific binding proteins for growth hormone in normal human sera
3. Growth hormone receptor and serum binding protein: Purification, cloning and expression
4. The circulating growth hormone (GH)-binding protein complex: A major constituent of plasma GH in man
5. Plasma transport of human growth hormone in vivo
6. Circulating growth hormone binding proteins
7. The serum growth hormone binding protein: Pregnant with possibilities
8. Regulation of the growth hormone binding proteins in human plasma
9. Regulation of the growth hormone (GH) receptor and GH-binding protein by GH pulsatility
10. Growth hormone-binding proteins: State of the art
11. Growth hormone-binding protein activity is inversely related to 24-hour growth hormone release in normal boys
12. Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency
13. Absence of the plasma growth hormone-binding protein in Laron-type dwarfism
14. The little women of Loja: Growth hormone-receptor deficiency in an inbred population of southern Ecuador
15. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients
16. Diverse growth hormone receptor gene mutations in Laron syndrome
17. Growth hormone (GH) insensivity due to primary GH receptor deficiency
18. Phenotype: Genotype relationships in growth hormone insensitivity syndrome
19. Serum growth hormone (GH)-binding protein/receptor: An important determinant of GH responsiveness
20. Growth hormone and prolactin-binding proteins in mammalian serum
21. A growth hormone binding factor in the serum of pregnant mice
22. Mouse serum growth hormone (GH) binding protein has GH receptor extracellular and substituted transmembrane domains
23. The growth hormone binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor
24. Identification of growth hormone binding protein in rat serum
25. Initial characterization and sexual dimorphism of serum growth hormone-binding protein in adult rats
26. Detection of glycosytated growth hormone binding proteins in rat serum
27. Identification and partial purification of serum growth hormone binding protein in domestic animal species
28. Growth hormone-binding protein in the goat: Characterization, evolution under exogenous growth hormone treatment, and correlation with liver growth hormone receptor levels
29. Presence of growth hormone-binding proteins in cattle plasma and milk
30. Evidence for the specific binding of growth hormone to a receptor-like protein in rabbit serum
31. Monkey growth hormone (GH) receptor gene expression. Evidence for two mechanisms for the generation of the GH binding protein
32. Variable evolutionary rates in the molecular evolution of mammalian growth hormones
33. Mouse growth hormone-binding protein and growth hormone receptor transcripts are produced from a single gene by alternative splicing
34. Evidence for generation of the growth hormone binding protein through proteolysis of the growth hormone membrane receptor
35. Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein
36. Growth hormone-binding proteins
37. Regulation of growth hormone-binding protein
38. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein
39. A membrane-fixed, truncated isoform of the human growth hormone receptor
40. Evolutionary divergence of the truncated growth hormone receptor isoform in its ability to generate a soluble growth hormone binding protein
41. Growth hormone and insulin binding to human liver
42. Growth hormone receptor gene expression in human digestive tissues
43. Localization of growth hormone receptor messenger RNA in human tissues
44. Regulation of growth hormone-binding proteins in health and disease
45. Decreased serum growth hormone-binding protein in patients with liver cirrhosis
46. Serum growth hormone-binding protein, insulin-like growth factor-I and growth hormone in patients with liver cirrhosis
47. GHBP in partially hepatectomized rats
48. Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues
49. Expression and binding properties of two isoforms of the human growth hormone receptor
50. Regulation of the celt surface growth hormone receptor
51. Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts
52. Hormonal regulation of growth hormone receptors in primary cultured rat hepatocytes
53. Glucose regulation of growth hormone receptors in primary cultured rat hepatocytes
54. Dexamethasone increases and serum decreases growth hormone receptor binding to UMR-106.01 rat osteosarcoma cells
55. Expression of growth hormone receptor by peripheral blood tymphocytes in children: Evaluation in clinical conditions of impaired growth
56. The role of body mass in the response growth hormone therapy
57. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins
58. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-1 (IGF-1) and IGF-1 receptors in obesity and anorexia nervosa
59. Nutritional status and growth hormone-binding protein
60. Serum growth hormone-binding protein in obesity: Effect of a short-term, very low calorie diet and diet-induced weight loss
61. GH-binding protein in obese men with varing glucose tolerance: Relationship to body fat distribution, insulin secretion and the GH-IGF-I axis
62. Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults
63. Spliced variants of the GH receptor are variably expressed at low levels in human tissues
64. Identification of phenylalanine 346 in the rat growth hormone receptor as being critical for ligand-mediated internalization and down-regulation
65. Studies with a growth hormone antagonist and dual-fluorescent confocal microscopy demonstrate that the full-length human growth hormone receptor, but not the truncated isoform, is very rapidly internalized independent of Jak2-Stat5 signaling
66. Cellular mechanisms in the processing of growth hormone and its receptor
67. The cellular mechanism of growth hormone signal transduction
68. Growth hormone receptor structure, dimerization and function
69. Binding in the growth hormone receptor complex
70. Intracellular processing of growth hormone receptors by adipocytes in primary culture
71. Blockade of growth hormone receptor shedding by a metalloprotease inhibitor
72. GH receptor proteolysis GH binding protein shedding effects of proteasome inhibition JAK2 deficiency
73. A metalloproteinase disintegrin that releases tumor-necrosis factor-α from cells
74. ADAMs: Focus on the protease domam
75. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
76. The metzincins-topological and sequential relations between the astacins, adamaiysins, serraiysins, and matrixins (collagenases) define a superfamily of zinc-peptidases
77. Role of the juxtamembrane domains of the transforming growth factor-α precursor and the β-amyloid precursor protein in regulated ectodomain shedding
78. Pro-tumor necrosis factor-α processing activity is tightly controlled by a component that does not affect notch processing
79. Release of growth hormone binding protein from IM-9 lymphocytes by endopeptidase is dependent on sulfhydryl group inactivation1
80. Comparison between the human serum growth hormone-binding protein and the watersoluble growth hormone-binding site released from IM-9 lymphocytes
81. The Hep G2 cell line in the study of growth hormone receptor/binding protein
82. Control of growth hormone (GH) binding protein release from human Hepatoma cells expressing full-length GH receptor Endocrinology
83. Regulation of cellular rabbit growth hormone (GH) receptor and GH-binding protein generation in vitro
84. The human growth hormone (GH) receptor and its truncated isoform: Sulfhydryl group inactivation in the study of receptor internalization and GH-binding protein generation
85. Activation of protein kinase Cα enhances human growth hormone-binding protein release Mol Cell Endocrinol
86. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a tack of intracellular domain
87. A dominant-negative mutation of the growth hormone receptor causes familial short stature (letter)
88. Cirrhotic liver expresses low levels of the full-length and truncated growth hormone receptors
89. Laron-type dwarfism with apparently normal high affinity serum growth hormone-binding protein
90. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome)
91. A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization
92. Molecular basis of inherited growth hormone resistance in childhood
93. A homozygous splice site mutation affecting the intracellular domain of the growth hormone receptor resulting in Laron syndrome with elevated GH binding protein
94. The D152H mutation found in growth hormone (GH) insensitivity syndrome impairs expression and function of human GH receptor but is silent in rat receptor
95. Serum growth hormon binding protein activity in healthy neonates, children and young adults: Correlation with age, height and weight
96. Evaluation of the growth hormone-binding proteins in human plasma using high pressure liquid chromatography
97. Binding protein for human growth hormone: Effects of age and weight
98. Growth hormone-binding protein-related immunoreactivity in the serum of patients with acromegaly is regulated inversely by growth hormone concentration
99. Growthhormone binding-protein in patients with acromegaly
100. Serum levels of growth hormone-binding protein and insulin-like growth factor-I during puberty